198HO02073 MORRICONE

Print/PDF
Registration Name GO-FARM MORRICONE TV TL TY
Registration Number HOITA019991411048
Primary NAAB Code 198HO02073
Secondary Code(s)
Status Inactive
Controller Name INTERMIZOO S.p.A. (198)
Date of Birth 9/16/2015
aAa 243165
DMS -
GFI 7.7%
Genetic Codes * TL TV TY
Haplotypes HH1T, HH2T, HH3T, HH4T, HH5T, HH6T, HCD-T
Sire SPINAL PRINCE MILITO TV TL TY
MGS ROYAL JEEVES SCOLARI-ET
Beta Casein A1A1
Kappa Casein AA
Beta Lactoglobulin AB
INDEXES
NM$ -364, 79% R CM$ -355
NM Percentile 09% FM$ -388
GTPI 2114 GM$ -376
PRODUCTION TRAITS
194 Dtrs 120 herds 0 % US 88% R
Milk -1066 Fat, % -45 , 0.00%
SCS 3, 87% R Protein, % -25 , +0.04%
Feed Saved -189 , 50% R Milking Speed 6.56 , 60% R
Health & Fertility
Productive Life 0.8      84% R Mastitis -0.2      71% R
Heifer Livability 0.4       49% R Metritis -0.9      67% R
Livability 1.0      78% R D. Abom -0.8      70% R
DPR 1.6      85% R Ketosis -1.5      66% R
FSC 0.9      74% R R. Placenta 0.2      68% R
HCR 1.3      78% R Milk Fever -0.1      59% R
CCR 0.9      84% R
SCR -        -
DIA 1.1      38% R
RSP 2.0      42% R
Calving Traits
Sire CE 1.3      35% R 141 Obs
Daughter CE 2.1      26% R 0 Obs, 165 Dtrs
Sire SB 4.1      29% R 381 Obs
Daughter SB 5.7      36% R 0 Obs, Dtrs
Gestation Length 1.6      76% R 0 Obs, 0 Dtrs
Early First Calving -0.6      73% R 0 Obs, 0 Dtrs

CDCB August 2026; Base of Evaluation: HO

* Individual bull owners may test for more recessives

Composites HA 08/2026
139 Dtrs 95 herds 70% R
PTA Type -0.80 UDC -0.50
HCC 0.45 BWC 0.58
FLC 0.28
Linear Traits
Stature -0.22
Short
Strength -0.27
Weak
Body Depth -1.17
Shallow
Dairy Form -1.99
Closed
Rump Angle 0.02
Sloped
Thurl Width -0.11
Sloped
Rear Legs-Side View -0.11
Narrow
Rear Legs-Rear View 0.08
Straight
Foot Angle 0.60
Steep
Feet & Legs Score 0.23
High
F.U. Attachment -0.50
Straight
Rear Udder Height -1.21
Low
Rear Udder Width -1.29
Narrow
Udder Cleft -0.03
Weak
Udder Depth 0.08
Straight
Front Teat Placement -2.17
Wide
Rear Teat Placement -1.00
Wide
Teat Length 0.76
Long
-2
0
2

CDCB August 2026; Base of Evaluation: HO